https://www.selleckchem.com/pr....oducts/edralbrutinib
82, 95% confidence interval 0.73-0.92). These risk estimates were attenuated in heavy smokers. We found slightly decreased risk estimates of COPD and lung cancer among smokers taking enzyme-inducing ASDs and hypothesise that this may be related to induction of detoxification of tobacco-specific lung toxins. We found slightly decreased risk estimates of COPD and lung cancer among smokers taking enzyme-inducing ASDs and hypothesise that this may be related to induction of detoxification of tobacco-specific lung toxins. Results from
Like
Comment
Share
